Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Change in Accured Expenses: 2021-2024

Historic Change in Accured Expenses for Cellebrite DI (CLBT) over the last 2 years, with Dec 2024 value amounting to $11.7 million.

  • Cellebrite DI's Change in Accured Expenses rose 110.41% to $11.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $31.4 million, marking a year-over-year increase of 190.97%. This contributed to the annual value of $17.6 million for FY2024, which is 2295.91% up from last year.
  • According to the latest figures from Q4 2024, Cellebrite DI's Change in Accured Expenses is $11.7 million, which was up 27.64% from $9.2 million recorded in Q3 2024.
  • In the past 5 years, Cellebrite DI's Change in Accured Expenses registered a high of $11.7 million during Q4 2024, and its lowest value of -$11.1 million during Q2 2022.
  • Moreover, its 3-year median value for Change in Accured Expenses was $4.9 million (2023), whereas its average is $2.9 million.
  • Per our database at Business Quant, Cellebrite DI's Change in Accured Expenses slumped by 184.84% in 2022 and then spiked by 370.44% in 2023.
  • Over the past 4 years, Cellebrite DI's Change in Accured Expenses (Quarterly) stood at $2.4 million in 2021, then tumbled by 184.84% to -$2.1 million in 2022, then skyrocketed by 370.44% to $5.6 million in 2023, then surged by 110.41% to $11.7 million in 2024.
  • Its Change in Accured Expenses was $11.7 million in Q4 2024, compared to $9.2 million in Q3 2024 and $5.6 million in Q4 2023.